FWD: Dr. Brad Kahl on lymphoma

[Guest guest]

Dan writes:

http://bit.ly/buRYIi

Contains 3 recent interviews with leading Follicular Lymphoma expert Dr.

Brad Kahl of the University of Wisconsin talking about results/findings from

Dec. '09 ASH conference:

- Excitement of CAL-101 as a new game-changing agent in fNHL, MM and CLL

- R-Bendamustine as the best frontline therapy for newly diagnosed fNHL

patients

- General discussion of " are we making progress? "

Dr. Kahl explains things in a very easy-to-understand manner.

All the best,

~ Karl